Curaleaf Holdings Inc T.CURA

Alternate Symbol(s): CURLF

Healthcare Cannabis

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

TSX:CURA - Post by User

Curaleaf Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Mar 04, 2022 8:24am

130 Views

Post# 34482316

Canaccord

Canaccord Genuity’s Matt Bottomley cut his Curaleaf Holdings Inc. target to $15.50 from $18 with a “buy” rating. The average is $23.30.

“After lowering our near-term estimates for CURA’s softened 2022 outlook and adding another 50 basis points premium to our overall SOTP discount rate to account for continued macro-level headwinds to start 2022, we are lowering our PT,” he said.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments